Michael DeGeorge
Keine laufenden Positionen mehr
Profil
Michael DeGeorge served as Director-Medical Affairs at Ameritox LLC from 2011 to 2015 and as Vice President-Medical Affairs at Collegium Pharmaceutical, Inc. from 2015 to 2022.
He received his undergraduate degree from St. John's University in 2000 and his doctorate from the University of Florida in 2004.
Ehemalige bekannte Positionen von Michael DeGeorge
| Unternehmen | Position | Ende |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Chief Tech/Sci/R&D Officer | - |
Ameritox LLC
 Ameritox LLC Medical/Nursing ServicesHealth Services Ameritox Ltd. engages in the development of pain medication monitoring solutions for pain management. The firm offers laboratory services and practice management tools to help clinicians coordinate and optimize the care of chronic pain patients. Its pain medication monitoring solutions include the Rx Guardian process, a urine drug testing to help clinicians assess whether patients are taking their medications correctly. The company was founded by Ronald C. Backer and Joel A. McEndree in 1996 and is headquartered in Columbia, MD. | Chief Tech/Sci/R&D Officer | 01.07.2015 |
Ausbildung von Michael DeGeorge
| St. John's University | Undergraduate Degree |
| University of Florida | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Ameritox LLC
Ameritox LLC Medical/Nursing ServicesHealth Services Ameritox Ltd. engages in the development of pain medication monitoring solutions for pain management. The firm offers laboratory services and practice management tools to help clinicians coordinate and optimize the care of chronic pain patients. Its pain medication monitoring solutions include the Rx Guardian process, a urine drug testing to help clinicians assess whether patients are taking their medications correctly. The company was founded by Ronald C. Backer and Joel A. McEndree in 1996 and is headquartered in Columbia, MD. | Health Services |
